Stockscreener 앱 받기
9.22
2.64%
-0.25
Grifols Sa Adr 주식(GRFS)의 최신 뉴스
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Is it possible to buy Grifols SA ADR(GRFS) shares at a good price now? - US Post News
Grifols SA ADR (GRFS)’s Day in Review: Closing at 8.58, Down by -0.12 - The Dwinnex
RFID Kanban Systems Market Forecast to Reach $9.53 Billion by 2030 - GlobeNewswire Inc.
A Look at Grifols SA ADR (GRFS) Shares in the Recent Past Indicates Growth - SETE News
Cboe Global Markets Inc. (AMEX: CBOE): Getting A Free Pass? - Stocks Register
It is Poised to be a Bull Market for Grifols SA ADR (GRFS) - SETE News
Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down (NASDAQ:GRFS) - Seeking Alpha
Examining Grifols SA ADR (GRFS) stock is warranted - US Post News
Are Grifols SA ADR’shares a good deal? - US Post News
Financial Health Report: Grifols SA ADR (GRFS)’s Ratios Tell a Tale - The Dwinnex
Was anything negative for Grifols SA ADR (GRFS) stock last session? - US Post News
Ratio Review: Analyzing Grifols SA ADR (GRFS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
GRFS’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
How does Grifols SA ADR (GRFS) change from a tortoise to a hare? - SETE News
Mexico Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research
The Significance of Moving Averages in Grifols SA ADR Inc. (GRFS) Price Performance - The InvestChronicle
Have you been able to find a good deal on Grifols SA ADR’s shares? - US Post News
Closing Figures: Grifols SA ADR (GRFS)’s Negative Finish at 8.41, Down -1.87 - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Grifols SA ADR (GRFS) - SETE News
Analytical Overview: Grifols SA ADR (GRFS)’s Ratios Tell a Financial Story - The Dwinnex
Investing in Grifols SA ADR (GRFS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Grifols Class B stock falls as Brookfield reportedly seeks lower price - MSN
Grifols Class B stock discounted by Brookfield (NASDAQ:GRFS) - Seeking Alpha
An analyst sees good growth prospects for Grifols SA ADR (GRFS) - SETE News
Grifols SA ADR [GRFS] Is Currently 1.11 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Grifols SA ADR (GRFS)’s Market Momentum: Closing Strong at 9.00, Up 2.74 - The Dwinnex
Grifols SA ADR (GRFS) looking to reclaim success with recent performance - SETE News
Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday - Yahoo Finance
Is the Grifols SA ADR (NASDAQ:GRFS) stock an investment opportunity? - US Post News
Get in on Grifols SA ADR’s (GRFS) buy-in window today! - SETE News
Grofols stock gains as Brookfield eyes takeover (NASDAQ:GRFS) - Seeking Alpha
Market Update: Grifols SA ADR (GRFS) Sees Positive Movement, Closing at 7.18 - The Dwinnex
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
How did Grifols SA ADR (GRFS) fare last session? - US Post News
Ratios Revealed: Decoding Grifols SA ADR (GRFS)’s Financial Health - The Dwinnex
Grifols SA ADR: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle
Are Investors Inclined To Sell Their Bath & Body Works Inc (NYSE: BBWI) Holdings? - Stocks Register
Does Uranium Royalty Corp (NASDAQ: UROY) Still Need To Convince Analysts? - Stocks Register
What Do Wall Street Analysts Think About Tetra Technologies, Inc. (NYSE: TTI) Stock? - Stocks Register
What Did We Find About Insider Trading At Monster Beverage Corp. (NASDAQ: MNST)? - Stocks Register
The growth track for Grifols SA ADR (GRFS) has changed recently - SETE News
India Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research
Investing in Grifols SA ADR (GRFS) might be a great opportunity, but the stock is a bit overvalued - US Post News
Validea Joseph Piotroski Strategy Daily Upgrade Report8/6/2024 - Nasdaq
Grifols SA ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Our Attention Has Been Attracted to Grifols SA ADR (NASDAQ:GRFS) - US Post News
Grifols revises past financial records with equity value drop of $494 mln - Marketscreener.com
Grifols SA ADR (GRFS) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
You might want to take a look at Grifols SA ADR (GRFS) now - SETE News
A stock that deserves closer examination: Grifols SA ADR (GRFS) - US Post News
Grifols SA ADR (NASDAQ: GRFS): Should Value Hunters Buy It? - Stocks Register
Market Insight: Grifols SA ADR (GRFS)’s Notable Drop, Closing at 8.16 - The Dwinnex
There is no way Grifols SA ADR (GRFS) can keep these numbers up - SETE News
Grifols: Going Private? Brookfield On The Scene (OTCMKTS:GIFLF) - Seeking Alpha
Grifols SA ADR (GRFS) Stock: Navigating a Year of Volatility - The InvestChronicle
Daily Market Movement: Grifols SA ADR (GRFS) Sees a 6.45 Increase, Closing at 8.91 - The Dwinnex
Is Grifols SA ADR (GRFS) a good investment opportunity? - US Post News
A better buy-in window may exist right now for Grifols SA ADR (GRFS) - SETE News
GRFS’s 2023 Market Dance: Down -26.38% – Time to Invest? - The InvestChronicle
Grifols receives takeover interest from its founding family, Brookfield fund; to go private - Seeking Alpha
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Canada Shine On
Grifols SA ADR (GRFS) looking to reclaim success with recent performance – Sete News - SETE News
1.03%
1.71%
자본화:
|
볼륨(24시간):